Takashi Matsui to Myocardial Ischemia
This is a "connection" page, showing publications Takashi Matsui has written about Myocardial Ischemia.
Connection Strength
0.607
-
Matsui T, Rosenzweig A. Targeting ischemic cardiac dysfunction through gene transfer. Curr Atheroscler Rep. 2003 May; 5(3):191-5.
Score: 0.217
-
Matsui T, Tao J, del Monte F, Lee KH, Li L, Picard M, Force TL, Franke TF, Hajjar RJ, Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation. 2001 Jul 17; 104(3):330-5.
Score: 0.192
-
Aoyagi T, Kusakari Y, Xiao CY, Inouye BT, Takahashi M, Scherrer-Crosbie M, Rosenzweig A, Hara K, Matsui T. Cardiac mTOR protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2012 Jul; 303(1):H75-85.
Score: 0.101
-
Chao W, Matsui T, Novikov MS, Tao J, Li L, Liu H, Ahn Y, Rosenzweig A. Strategic advantages of insulin-like growth factor-I expression for cardioprotection. J Gene Med. 2003 Apr; 5(4):277-86.
Score: 0.054
-
Matsui T, Li L, Fukui Y, Franke TF, Hajjar RJ, Rosenzweig A. Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation. 1999 Dec 07; 100(23):2373-9.
Score: 0.043